US FDA completed its review of the VivaGel® BV NDA and advised it requires confirmatory clinical data prior to approval. In preparation for a meeting with the FDA to discuss the data required, Starpharma has been working closely with expert FDA consultants and is currently awaiting confirmation of the meeting date;
Confirmation of meeting date? They still haven't confirmed a date?????
SPL Price at posting:
$1.04 Sentiment: Buy Disclosure: Held
